ANAPTYSBIO, INC — Director's Dealing 2021

Nov 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2021-11-04

Reporting Person: Suria Hamza (Director, President, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common Stock	M	6059	$1.12	Acquired	73695	Direct
2021-11-04	Common Stock	S	6059	$35.00	Disposed	67636	Direct
2021-11-05	Common Stock	M	14302	$1.12	Acquired	81938	Direct
2021-11-05	Common Stock	S	14302	$35.00	Disposed	67636	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Employee Stock Option (Right to Buy)	$1.12	M	6059	Disposed	2021-12-08	Common Stock (6059)	Direct
2021-11-05	Employee Stock Option (Right to Buy)	$1.12	M	14302	Disposed	2021-12-08	Common Stock (14302)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

F2: The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021.

F3: In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly.